ALLOZYNE
Allozyne develops and commercializes technologies that enable improvements in the efficacy, safety, dosing, and other characteristics of protein-based therapeutics, including peptides, antibodies, and vaccines. Its PEGylated IFN beta is for the treatment of multiple sclerosis. The company was founded in 2005 and is based in Seattle, Washington.
ALLOZYNE
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2005-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.allozyne.com
Total Employee:
11+
Status:
Active
Contact:
206-518-5700
Email Addresses:
[email protected]
Total Funding:
36.9 M USD
Technology used in webpage:
Viewport Meta SPF Google Analytics LetsEncrypt Google Universal Analytics Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS AJAX Libraries API
Current Advisors List
Current Employees Featured
Founder
Investors List
OVP Venture Partners
OVP Venture Partners investment in Series B - Allozyne
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Series B - Allozyne
Amgen Ventures
Amgen Ventures investment in Series B - Allozyne
MPM Capital
MPM Capital investment in Series B - Allozyne
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Allozyne
MPM Capital
MPM Capital investment in Series A - Allozyne
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Allozyne
Amgen Ventures
Amgen Ventures investment in Series A - Allozyne
OVP Venture Partners
OVP Venture Partners investment in Series A - Allozyne
Official Site Inspections
http://www.allozyne.com
- Host name: 115.130.96.66.static.eigbox.net
- IP address: 66.96.130.115
- Location: Burlington United States
- Latitude: 42.509
- Longitude: -71.1984
- Metro Code: 506
- Timezone: America/New_York
- Postal: 01803
